Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

SIGNATURE SInGle cells iN AuToimmUne inflammatoRy disEases

Coordinator
Fundacion Publica Andaluza Progreso Y Salud M.p., Spain
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€2.6m
Total cost
—
Partners
16 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101072891

What the project is doing

In the project's own words, from its summary on CORDIS.

Autoimmune disorders are highlyImmune-mediated disorders are highly heterogenenous entities for which the mechanisms of disease progression and therapeutic responses are only recently beginning to be understood. The patterns of transcriptome are the reflection of distinct cell types that are involved in the development of the disease process. Our plan is to approach the diseases beginning from a global view that allows us to then come down to the most relevant cell types in tissues and blood.

In addition, by understanding disease heterogeneity and diseases similarities, we can also identify the best pathways to be targeted with specific biological treatments. The diseases involved are systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, asthma, chronic obstructive pulmonary disease, Crohn´s disease and ulcerative colitis. Based on a unique ongoing platform of clinical groups across Europe and specialists in cell and molecular profiling, imaging analyses, single cell sequencing and analysis, we will identify the molecular basis of each of the diseases heterogeneity, the mechanisms of treatment non responsiveness, and develop a specialized training program where students will be able to visualize the overall work from design to analysis of the data and become engaged in the unique multi-disciplinariry of this platform.

The platform will have available existing clinical studies and clinical trials, but will be also producing new data from prospective studies where samples and tissues for each disease, based on the appropriate indications will be obtained with special protocols, for the study. The engaged students will be permeated by the latest advances in not one, but several new approaches and systems biology modelling, and develop out-of-the-box concepts where diseases can be viewed not as separate clinical entities but as novel groups of shared molecular and cellular patterns that impinge on specific tissues by specialized cell types.

Topics

Who is involved

OrganisationCityCountryRole
Fundacion Publica Andaluza Progreso Y Salud M.p.SevillaSpainCoordinator
Universiteit GentGentBelgiumAssociatedpartner
Vib VzwZwijnaarde - GentBelgiumParticipant
Deutsches Rheuma ForschungszentrumberlinBerlinGermanyParticipant
Technische Universitat BerlinBerlinGermanyAssociatedpartner
Atrys Health SAMadridSpainParticipant
Consorcio Para La Explotacion Del Centro Nacional De Analisis GenomicoBarcelonaSpainParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Universidad De GranadaGranadaSpainAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainAssociatedpartner
AltrabioLyonFranceParticipant
Standard Biotools France SARLParisFranceAssociatedpartner
Universite De BrestBrestFranceParticipant
Universita Degli Studi Di CataniaCataniaItalyParticipant
Omniscope LimitedMostaMaltaAssociatedpartner
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI